Where rare is common

Our breast pathology consultative service receives thousands of cases each year, spanning the spectrum of benign breast disease and diagnostically-challenging atypical lesions to conventional carcinomas and rare variants. We are fortunate to have expansive molecular and immunohistochemistry test menus to aid with diagnosis of rare breast tumors, and to have expertise in breast biomarker and companion diagnostic testing.

3,000+

breast consult cases seen each year

13,500

breast biomarker assays performed each year

7

sub-specialized pathologists

Requesting a pathology consult

Our best practices enable expeditious, evidence-based results. Click here to learn more about Mayo Clinic Laboratories consultation request process.

Jodi Carter, M.D., Ph.D.

Breast pathologist and associate professor of Laboratory Medicine and Pathology

Beiyun Chen, M.D., Ph.D.

Head of Breast Pathology Section, breast pathologist, and associate professor of Laboratory Medicine and Pathology

Rafael Jimenez, M.D.

Breast pathologist and associate professor of Laboratory Medicine and Pathology

Gary Keeney, M.D.

Breast pathologist and professor of Laboratory Medicine and Pathology

Malvika Solanki, M.B.B.S., Ph.D.

Breast pathologist and assistant professor of Laboratory Medicine and Pathology

Charles Sturgis, M.D.

Breast pathologist and professor of Laboratory Medicine and Pathology

Saba Yasir, M.B.B.S.

Breast pathologist and assistant professor of Laboratory Medicine and Pathology

Testing

PATHC | Pathology Consultation

22C3 | Programmed Death-Ligand 1 (PD-L1) (22C3), Semi-Quantitative Immunohistochemistry, Manual

AREC | Androgen Receptor (AR) Immunostain, Technical Component Only

ERPR | Estrogen/Progesterone Receptor, Semi-Quantitative Immunohistochemistry, Manual

KI67B | Ki-67(MIB-1), Breast, Quantitative Immunohistochemistry, Automated

SP142 | Programmed Death-Ligand 1 (PD-L1) (SP142), Semi-Quantitative Immunohistochemistry, Manual